NIH-funded research R01 grant

Investigating how amphiregulin affects bladder issues in cancer survivors after radiation therapy

Official title: The role of amphiregulin in mediating radiation cystitis in cancer survivors

Funded at William Beaumont Hospital Research Inst · NIH-11103384 · Data updated 2026-11-12

This study is looking at how a protein called amphiregulin affects bladder problems in cancer survivors who have had radiation therapy, with the hope of finding better ways to diagnose and treat this painful condition.

More Cancer Survivors research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWilliam Beaumont Hospital Research Inst
NIH-funded
Lab location1 site (Royal Oak, United States)
Project startApril 15, 2023
Project endFebruary 29, 2028
Funding year2025
Award (this year)$460,815
NIH project number5R01DK135986-03
Project IDNIH-11103384 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are cancer survivors who have experienced bladder issues following radiation therapy for pelvic cancers.

Less likely to help

Patients who have not undergone radiation therapy or do not have symptoms of radiation cystitis may not benefit from this research.

What this research studies

This research focuses on understanding radiation cystitis, a painful bladder condition that can develop in cancer survivors who have undergone radiation therapy for pelvic cancers. The study aims to explore the role of a protein called amphiregulin in the development and progression of this condition. By using a preclinical model that mimics human radiation cystitis, researchers will investigate how amphiregulin levels change over time and how they relate to bladder damage. The ultimate goal is to identify new diagnostic and therapeutic strategies to improve the quality of life for affected patients.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that alleviate the debilitating symptoms of radiation cystitis in cancer survivors.

How similar studies have gone: While research on radiation cystitis is ongoing, the specific investigation of amphiregulin's role in this context is relatively novel and has not been extensively tested.

Where this research is happening

  • William Beaumont Hospital Research Inst
    Royal Oak, United States
    Active

Researchers

  • Principal investigator: Zwaans, Bernadette Margaretha Maria — William Beaumont Hospital Research Inst
  • Study coordinator: Zwaans, Bernadette Margaretha Maria

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.